{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:53:56Z","timestamp":1770994436040,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11102-019-00992-6","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T08:03:08Z","timestamp":1569312188000},"page":"607-613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing\u2019s disease"],"prefix":"10.1007","volume":"22","author":[{"given":"Alexander D.","family":"Sherry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-221X","authenticated-orcid":false,"given":"Mohamed H.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Utz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lola B.","family":"Chambless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Cmelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"992_CR1","first-page":"137","volume":"50","author":"H Cushing","year":"1932","unstructured":"Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137\u2013195","journal-title":"Bull Johns Hopkins Hosp"},{"key":"992_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jama.1932.02740560007003","volume":"99","author":"H Cushing","year":"1932","unstructured":"Cushing H (1932) Further notes on pituitary basophilism. JAMA 99:281\u2013284","journal-title":"JAMA"},{"key":"992_CR3","first-page":"12","volume":"9","author":"A Buliman","year":"2016","unstructured":"Buliman A, Tataranu L, Paun D et al (2016) Cushing\u2019s disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment. J Med Life 9:12\u201318","journal-title":"J Med Life"},{"key":"992_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11102-014-0569-6","volume":"18","author":"MS Broder","year":"2015","unstructured":"Broder MS, Neary MP, Chang E et al (2015) Incidence of Cushing\u2019s syndrome and Cushing\u2019s disease in commercially-insured patients %3c65 years old in the United States. Pituitary 18:283\u2013289. \nhttps:\/\/doi.org\/10.1007\/s11102-014-0569-6","journal-title":"Pituitary"},{"key":"992_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1210\/edrv.20.2.0358","volume":"20","author":"PLM Dahia","year":"1999","unstructured":"Dahia PLM, Grossman AB (1999) The molecular pathogenesis of corticotroph tumors. Endocr Rev 20:136\u2013155. \nhttps:\/\/doi.org\/10.1210\/edrv.20.2.0358","journal-title":"Endocr Rev"},{"key":"992_CR6","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing\u2019s syndrome. Lancet 367:1605\u20131617. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(06)68699-6","journal-title":"Lancet"},{"key":"992_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/er.2013-1048","volume":"36","author":"R Pivonello","year":"2015","unstructured":"Pivonello R, De Leo M, Cozzolino A, Colao A (2015) The treatment of cushing\u2019s disease. Endocr Rev 36:385\u2013486. \nhttps:\/\/doi.org\/10.1210\/er.2013-1048","journal-title":"Endocr Rev"},{"key":"992_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","volume":"37","author":"R Pivonello","year":"2008","unstructured":"Pivonello R, De Martino M, De Leo M et al (2008) Cushing\u2019s syndrome. Endocrinol Metab Clin North Am 37:135\u2013149. \nhttps:\/\/doi.org\/10.1016\/j.ecl.2007.10.010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"992_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-11-1095","volume":"167","author":"RA Feelders","year":"2012","unstructured":"Feelders RA, Pulgar SJ, Kempel A, Pereira AM (2012) The burden of Cushing\u2019s disease: clinical and health-related quality of life aspects. Eur J Endocrinol 167:311\u2013326. \nhttps:\/\/doi.org\/10.1530\/EJE-11-1095","journal-title":"Eur J Endocrinol"},{"key":"992_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","volume":"23","author":"D Graversen","year":"2012","unstructured":"Graversen D, Vestergaard P, Stochholm K et al (2012) Mortality in Cushing\u2019s syndrome: a systematic review and meta-analysis. Eur J Intern Med 23:278\u2013282. \nhttps:\/\/doi.org\/10.1016\/j.ejim.2011.10.013","journal-title":"Eur J Intern Med"},{"issue":"Suppl 1","key":"992_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4183\/aeb.2010.83","volume":"92","author":"RN Clayton","year":"2010","unstructured":"Clayton RN (2010) Mortality in Cushing\u2019s disease. Neuroendocrinology 92(Suppl 1):71\u201376. \nhttps:\/\/doi.org\/10.4183\/aeb.2010.83","journal-title":"Neuroendocrinology"},{"key":"992_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1210\/edrv-14-4-443","volume":"14","author":"JW Miller","year":"1993","unstructured":"Miller JW, Crapo L (1993) The medical treatment of cushing\u2019s syndrome. Endocr Rev 14:443\u2013458. \nhttps:\/\/doi.org\/10.1210\/edrv-14-4-443","journal-title":"Endocr Rev"},{"key":"992_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-0032-1330009","volume":"45","author":"A Juszczak","year":"2013","unstructured":"Juszczak A, Ertorer ME, Grossman A (2013) The therapy of cushing\u2019s disease in adults and children: an update. Horm Metab Res 45:109\u2013117. \nhttps:\/\/doi.org\/10.1055\/s-0032-1330009","journal-title":"Horm Metab Res"},{"key":"992_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2011.8.jns102005","volume":"116","author":"GU Mehta","year":"2012","unstructured":"Mehta GU, Lonser RR, Oldfield EH (2012) The history of pituitary surgery for Cushing disease. J Neurosurg 116:261\u2013268. \nhttps:\/\/doi.org\/10.3171\/2011.8.jns102005","journal-title":"J Neurosurg"},{"issue":"7","key":"992_CR15","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1210\/jc.2011-0251","volume":"96","author":"Jay S. Loeffler","year":"2011","unstructured":"Loeffler JS, Shih HA (2011) Radiation therapy in the management of pituitary adenomas [Review]. J Clin Endocrinol Metab 96:1992\u20132003. \nhttps:\/\/doi.org\/https:\/\/dx.doi.org\/10.1210\/jc.2011-0251","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"992_CR16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/cncr.22860","volume":"110","author":"DS Kong","year":"2007","unstructured":"Kong DS, Il Lee J, Do HL et al (2007) The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 110:854\u2013860. \nhttps:\/\/doi.org\/10.1002\/cncr.22860","journal-title":"Cancer"},{"key":"992_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0360-3016(98)00256-9","volume":"42","author":"M Mitsumori","year":"1998","unstructured":"Mitsumori M, Shrieve DC, Alexander E et al (1998) Initial clinical results of linac-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 42:573\u2013580. \nhttps:\/\/doi.org\/10.1016\/S0360-3016(98)00256-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"992_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1259\/bjr\/31372149","volume":"83","author":"JF Fowler","year":"2010","unstructured":"Fowler JF (2010) 21 Years of biologically effective dose. Br J Radiol 83:554\u2013568. \nhttps:\/\/doi.org\/10.1259\/bjr\/31372149","journal-title":"Br J Radiol"},{"key":"992_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1227\/01.NEU.0000114261.18723.6A","volume":"54","author":"CJ Pham","year":"2004","unstructured":"Pham CJ, Chang SD, Gibbs IC et al (2004) Preliminary visual field preservation after staged CyberKnife radiosurgery for perioptic lesions. Neurosurgery 54:799\u2013810. \nhttps:\/\/doi.org\/10.1227\/01.NEU.0000114261.18723.6A","journal-title":"Neurosurgery"},{"key":"992_CR20","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1227\/01.NEU.0000223512.09115.3E","volume":"59","author":"JR Adler","year":"2006","unstructured":"Adler JR, Gibbs IC, Puataweepong P, Chang SD (2006) Visual field preservation after multisession CyberKnife radiosurgery for perioptic lesions. Neurosurgery 59:2442\u20132454. \nhttps:\/\/doi.org\/10.1227\/01.NEU.0000223512.09115.3E","journal-title":"Neurosurgery"},{"key":"992_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jocn.2013.03.024","volume":"21","author":"HI Liao","year":"2014","unstructured":"Liao HI, Wang CC, Wei KC et al (2014) Fractionated stereotactic radiosurgery using the Novalis system for the management of pituitary adenomas close to the optic apparatus. J Clin Neurosci 21:111\u2013115. \nhttps:\/\/doi.org\/10.1016\/j.jocn.2013.03.024","journal-title":"J Clin Neurosci"},{"key":"992_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000156557","volume":"21","author":"A Niranjan","year":"2008","unstructured":"Niranjan A, Flickinger JC (2008) Radiobiology, principle and technique of radiosurgery. Prog Neurol Surg 21:32\u201342. \nhttps:\/\/doi.org\/10.1159\/000156557","journal-title":"Prog Neurol Surg"},{"key":"992_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/neuonc\/nou284","volume":"17","author":"D Kondziolka","year":"2015","unstructured":"Kondziolka D, Shin SM, Brunswick A et al (2015) The biology of radiosurgery and its clinical applications for brain tumors. Neuro Oncol 17:29\u201344. \nhttps:\/\/doi.org\/10.1093\/neuonc\/nou284","journal-title":"Neuro Oncol"},{"key":"992_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0360-3016(93)90367-5","volume":"25","author":"EJ Hall","year":"1993","unstructured":"Hall EJ, Brenner DJ (1993) The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 25:381\u2013385. \nhttps:\/\/doi.org\/10.1016\/0360-3016(93)90367-5","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"992_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf 42:377\u2013381. \nhttps:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inf"},{"key":"992_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7","volume":"1","author":"W Cahan","year":"1948","unstructured":"Cahan W, Woodard H (1948) Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1:3\u201329","journal-title":"Cancer"},{"key":"992_CR27","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jc.81.7.2647","volume":"81","author":"N Sonino","year":"1996","unstructured":"Sonino N, Zielezny M, Fava GA et al (1996) Risk factors and long-term outcome in pituitary-dependent Cushing\u2019s disease. J Clin Endocrinol Metab 81:2647\u20132652. \nhttps:\/\/doi.org\/10.1210\/jc.81.7.2647","journal-title":"J Clin Endocrinol Metab"},{"key":"992_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2265.1989.tb01255.x","volume":"31","author":"T Howlett","year":"1989","unstructured":"Howlett T, Plowman P, Wass J et al (1989) Megavoltage pituitary irradiation in the management of Cushing\u2019s disease and Nelson\u2019s syndrome: long-term follow-up. Clin Endocrinol 31:309\u2013323","journal-title":"Clin Endocrinol"},{"key":"992_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1530\/acta.0.1250470","volume":"125","author":"A Vicente","year":"2009","unstructured":"Vicente A, Estrada J, de la Cuerda C et al (2009) Results of external pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing\u2019s disease. Acta Endocrinol (Copenh) 125:470\u2013474. \nhttps:\/\/doi.org\/10.1530\/acta.0.1250470","journal-title":"Acta Endocrinol (Copenh)"},{"key":"992_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00000421-199102000-00005","volume":"14","author":"LM Tran","year":"1991","unstructured":"Tran LM, Blount L, Horton D et al (1991) Radiation therapy of pituitary tumors: results in 95 cases. Am J Clin Oncol 14:25\u201329. \nhttps:\/\/doi.org\/10.1097\/00000421-199102000-00005","journal-title":"Am J Clin Oncol"},{"key":"992_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0360-3016(95)00071-6","volume":"33","author":"D Zierhut","year":"1995","unstructured":"Zierhut D, Flentje M, Adolph J et al (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307\u2013314. \nhttps:\/\/doi.org\/10.1016\/0360-3016(95)00071-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"992_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1056\/nejm199701163360303","volume":"336","author":"J Estrada","year":"1997","unstructured":"Estrada J, Boronat M, Mielgo M et al (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in cushing\u2019s disease. N Engl J Med 336:172\u2013177. \nhttps:\/\/doi.org\/10.1056\/nejm199701163360303","journal-title":"N Engl J Med"},{"key":"992_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-007-9344-0","volume":"84","author":"G Minniti","year":"2007","unstructured":"Minniti G, Osti M, Jaffrain-Rea ML et al (2007) Long-term follow-up results of postoperative radiation therapy for Cushing\u2019s disease. J Neurooncol 84:79\u201384. \nhttps:\/\/doi.org\/10.1007\/s11060-007-9344-0","journal-title":"J Neurooncol"},{"key":"992_CR34","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/cncr.22128","volume":"107","author":"J Voges","year":"2006","unstructured":"Voges J, Kocher M, Runge M et al (2006) Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 107:1355\u20131364. \nhttps:\/\/doi.org\/10.1002\/cncr.22128","journal-title":"Cancer"},{"key":"992_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/2010.5.jns091635","volume":"114","author":"JP Sheehan","year":"2011","unstructured":"Sheehan JP, Pouratian N, Steiner L et al (2011) Gamma knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114:303\u2013309. \nhttps:\/\/doi.org\/10.3171\/2010.5.jns091635","journal-title":"J Neurosurg"},{"key":"992_CR36","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1210\/jc.2008-2772","volume":"94","author":"F Castinetti","year":"2009","unstructured":"Castinetti F, Nagai M, Morange I et al (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94:3400\u20133407. \nhttps:\/\/doi.org\/10.1210\/jc.2008-2772","journal-title":"J Clin Endocrinol Metab"},{"key":"992_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000083476","volume":"82","author":"JK Devin","year":"2004","unstructured":"Devin JK, Allen GS, Cmelak AJ et al (2004) The efficacy of linear accelerator radiosurgery in the management of patients with Cushing\u2019s disease. Stereotact Funct Neurosurg 82:254\u2013262. \nhttps:\/\/doi.org\/10.1159\/000083476","journal-title":"Stereotact Funct Neurosurg"},{"key":"992_CR38","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3171\/jns.2007.106.6.980","volume":"106","author":"J Jagannathan","year":"2007","unstructured":"Jagannathan J, Sheehan J, Pouratian N et al (2007) Gamma knife surgery for Cushing\u2019s disease. J Neurosurg 106:980\u2013987. \nhttps:\/\/doi.org\/10.3171\/jns.2007.106.6.980","journal-title":"J Neurosurg"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-019-00992-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T23:14:11Z","timestamp":1600816451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-019-00992-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["992"],"URL":"https:\/\/doi.org\/10.1007\/s11102-019-00992-6","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]},"assertion":[{"value":"24 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Alexander Sherry declares that he has no conflicts of interest. Mohamed H. Khattab receives research funding support from Varian Medical Systems and Brainlab, Inc. Mark Xu declares that he has no conflicts of interest. Patrick Kelly declares that he has no conflicts of interest. Joshua Anderson declares that he has no conflicts of interest. Guozhen Luo declares that she has no conflicts of interest. Andrea Utz declares that she has no conflicts of interest. Lola Chambless declares that she has no conflicts of interest. Anthony Cmelak declares that he has no conflicts of interest. Albert Attia receives funding from Brainlab, AstraZeneca, and Novocure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived by the IRB due to the determination of minimal risk of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}